Suppr超能文献

特发性慢性呃逆:西沙必利、奥美拉唑和巴氯芬联合治疗

Idiopathic chronic hiccup: combination therapy with cisapride, omeprazole, and baclofen.

作者信息

Petroianu G, Hein G, Petroianu A, Bergler W, Rüfer R

机构信息

Department of Pharmacology and Toxicology, University of Heidelberg at Mannheim, Germany.

出版信息

Clin Ther. 1997 Sep-Oct;19(5):1031-8. doi: 10.1016/s0149-2918(97)80055-0.

Abstract

Idiopathic chronic hiccup (ICH) is defined as recurring hiccup attacks that last for longer than an arbitrary time limit (eg, 1 month) and for which no organic cause can be found. In patients with ICH, therapy is largely empiric. For practical purposes, idiopathic hiccup can be assumed to have its origin either in the viscera (gastrointestinal tract) or in the central nervous system. Cisapride and omeprazole--through reduction of gastric acid production and facilitation of gastric emptying, respectively--are thought to reduce an assumed afferent input from the periphery to a putative supraspinal hiccup center. Baclofen is thought to reduce excitability and depress reflex hiccup activity. Fifteen male patients (mean [+/- SD] age, 68.2 +/- 11.6 years) who had recurring hiccup attacks for a mean duration of 100.8 +/- 134.1 months (range, 12 to 564 months) were treated for ICH with a combination of cisapride, omeprazole, and baclofen (COB). Therapy led to a total disappearance of hiccup in 40% (6 of 15) of the treated patients. An additional 20% (3 of 15) of patients experienced substantial relief. A Mann-Whitney rank order test showed a highly significant reduction in the severity of the hiccup attacks as reflected in the subjective assessment scale scores taken before therapy (8.6 +/- 1.3) compared with those taken after 20 weeks of therapy (4.1 +/- 3.8). Thus we concluded that COB is an effective empiric therapy in at least some patients with ICH.

摘要

特发性慢性呃逆(ICH)的定义为反复出现的呃逆发作,持续时间超过一个任意设定的时限(如1个月),且找不到器质性病因。对于ICH患者,治疗在很大程度上是经验性的。出于实际目的,可认为特发性呃逆起源于内脏(胃肠道)或中枢神经系统。西沙必利和奥美拉唑——分别通过减少胃酸分泌和促进胃排空——被认为可减少假定的从外周至假定的脊髓上呃逆中枢的传入输入。巴氯芬被认为可降低兴奋性并抑制反射性呃逆活动。15名男性患者(平均[±标准差]年龄,68.2±11.6岁),其反复呃逆发作的平均持续时间为100.8±134.1个月(范围,12至564个月),接受了西沙必利、奥美拉唑和巴氯芬联合治疗(COB)以治疗ICH。治疗使40%(15例中的6例)的治疗患者呃逆完全消失。另外20%(15例中的3例)的患者症状大幅缓解。曼-惠特尼秩和检验显示,与治疗20周后的主观评估量表评分(4.1±3.8)相比,治疗前的评分(8.6±1.3)所反映的呃逆发作严重程度有极显著降低。因此我们得出结论,COB对至少部分ICH患者是一种有效的经验性治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验